A Randomized, Double-Blind and Double-Dummy, Multiple-dose, Multicenter, Positive Controlled, Parallel, Phase II Trial of Allisartan Isoproxil in Patients with Mild to Moderate Essential Hypertension.

Trial Profile

A Randomized, Double-Blind and Double-Dummy, Multiple-dose, Multicenter, Positive Controlled, Parallel, Phase II Trial of Allisartan Isoproxil in Patients with Mild to Moderate Essential Hypertension.

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Oct 2016

At a glance

  • Drugs Allisartan; Losartan
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 May 2012 Actual end date changed from Nov 2009 to 31 Jan 2009 as reported by Chinese Clinical Trial Register.
    • 21 May 2012 Actual initiation date changed from Jul 2008 to Aug 2008 as reported by Chinese Clinical Trial Register.
    • 09 Jan 2012 Actual initiation date changed from 1 Aug 2008 to 1 Jul 2008 as reported by Chinese Clinical Trial Register.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top